[YMAB] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -82.29%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 65,267 34,897 20,750 0 0 0 0 -
PBT -95,568 -55,275 -119,337 -81,028 -43,274 -19,161 -17,057 33.25%
Tax 757 1,070 -994 -2,142 -44 -19,244 -17,039 -
NP -96,325 -56,345 -118,343 -78,886 -43,274 -19,161 -17,057 33.42%
Tax Rate - - - - - - - -
Total Cost 161,592 91,242 139,093 78,886 43,274 19,161 17,057 45.43%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -147.59 -161.46 -570.33 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.20 -1.30 -2.95 -2.24 -1.50 -0.58 -0.51 27.57%
EPS Diluted -2.20 -1.30 -2.95 -2.24 -1.50 -0.58 -0.51 27.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.